﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="en" article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Korean J Physiol Pharmacol</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Physiology &#38; Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="publisher">Korean J. Physiol. Pharmacol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1226-4512</issn>
<issn pub-type="epub">2093-3827</issn>
<publisher>
<publisher-name>The Korean Physiological Society and The Korean Society of Pharmacology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4196/kjpp.2022.26.3.219</article-id>
<article-id pub-id-type="publisher-id">kjpp-26-3-219</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ca<sup>2+</sup> entry through reverse Na<sup>+</sup>/Ca<sup>2+</sup> exchanger in NCI-H716, glucagon-like peptide-1 secreting cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Choi</surname><given-names>Kyung Jin</given-names></name>
<xref rid="aff1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hwang</surname><given-names>Jin Wook</given-names></name>
<xref rid="aff1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Se Hoon</given-names></name>
<xref rid="aff1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Park</surname><given-names>Hyung Seo</given-names></name>
<xref rid="aff1" ref-type="aff">1</xref>
<xref rid="aff2" ref-type="aff">2</xref>
<xref rid="cor1" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Department of Physiology, College of Medicine, Konyang University, Daejeon 35365, <country>Korea</country></aff>
<aff id="aff2"><label>2</label>Myunggok Medical Research Institute, Konyang University, Daejeon 35365, <country>Korea</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Correspondence</bold> Hyung Seo Park, E-mail: <email xlink:href="hspark@konyang.ac.kr">hspark@konyang.ac.kr</email></corresp>
<fn fn-type="con">
<p><bold>Author contributions:</bold> K.J.C. and J.W.H. performed the experiments and analyzed the data. S.H.K. contributed to the conception and design of the study. H.S.P. coordinated the study and wrote the manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>5</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>5</month>
<year>2022</year>
</pub-date>
<volume>26</volume>
<issue>3</issue>
<fpage>219</fpage>
<lpage>225</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>2</month>
<year>2022</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>3</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>4</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#169; Korean J Physiol Pharmacol</copyright-statement>
<copyright-year>2022</copyright-year>
<license license-type="open-access">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Glucagon like peptide-1 (GLP-1) released from enteroendocine L-cells in the intestine has incretin effects due to its ability to amplify glucose-dependent insulin secretion. Promotion of an endogenous release of GLP-1 is one of therapeutic targets for type 2 diabetes mellitus. Although the secretion of GLP-1 in response to nutrient or neural stimuli can be triggered by cytosolic Ca<sup>2+</sup> elevation, the stimulus-secretion pathway is not completely understood yet. Therefore, the aim of this study was to investigate the role of reverse Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (rNCX) in Ca<sup>2+</sup> entry induced by muscarinic stimulation in NCI-H716 cells, a human enteroendocrine GLP-1 secreting cell line. Intracellular Ca<sup>2+</sup> was repetitively oscillated by the perfusion of carbamylcholine (CCh), a muscarinic agonist. The oscillation of cytosolic Ca<sup>2+</sup> was ceased by substituting extracellular Na<sup>+</sup> with Li<sup>+</sup> or NMG<sup>+</sup>. KB-R7943, a specific rNCX blocker, completely diminished CCh-induced cytosolic Ca<sup>2+</sup> oscillation. Type 1 Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX<sub>1</sub>) proteins were expressed in NCI-H716 cells. These results suggest that rNCX might play a crucial role in Ca<sup>2+</sup> entry induced by cholinergic stimulation in NCI-H716 cells, a GLP-1 secreting cell line.</p>
</abstract>
<kwd-group>
<kwd>Calcium entry</kwd>
<kwd>Carbamylcholine</kwd>
<kwd>Glucagon like peptide-1</kwd>
<kwd>NCI-H716</kwd>
<kwd>Na<sup>+</sup>/Ca<sup>2+</sup> exchanger</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Glucagon-like peptide-1 (GLP-1) secreted from intestinal enteroendocrine L-cells is an incretin that can augment glucose-dependent insulin secretion [<xref rid="ref1" ref-type="bibr">1</xref>]. GLP-1 is known to stimulate proinsulin gene expression and pancreatic &#946;-cell proliferation [<xref rid="ref2" ref-type="bibr">2</xref>,<xref rid="ref3" ref-type="bibr">3</xref>]. Promoting insulin secretin is a crucial goal when treating type 2 diabetes mellitus. Thus, stimulating endogenous release of GLP-1 has become one of therapeutic targets for diabetes [<xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref5" ref-type="bibr">5</xref>]. A number of cellular models, such as isolated primary intestinal L-cell and enteroendocrine cell lines STC-1, GLUTag, and NCI-H716 cells, have been used to study the regulation of GLP-1 secretion [<xref rid="ref6" ref-type="bibr">6</xref>,<xref rid="ref7" ref-type="bibr">7</xref>]. These cellular models provide useful information concerning signaling pathways that regulate GLP-1 secretion. NCI-H716 cells derived from poorly differentiated adenocarcinoma of human cecum have potent GLP-1 secreting properties. Nutrients, hormones, and neurotransmitters are known to control the release of GLP-1 in physiological conditions [<xref rid="ref8" ref-type="bibr">8</xref>,<xref rid="ref9" ref-type="bibr">9</xref>]. It has been reported that muscarinic agonist can stimulate GLP-1 secretion in NCI-H716 cells, and that such secretion is closely linked to G-protein coupled receptor activations and elevated cytosolic Ca<sup>2+</sup> signals [<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr"/>-<xref rid="ref12" ref-type="bibr">12</xref>]. Although GLP-1 secretion plays an important role in blood glucose control as mentioned above, the detail stimulus-secretion pathway in NCI-H716 cells is not completely understood yet.</p>
<p>Mammalian Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX) is a bi-directional Ca<sup>2+</sup> transporter that contributes to Ca<sup>2+</sup> homeostasis of multiple tissues such as cardiac muscle, skeletal muscle, brain, and kidney [<xref rid="ref13" ref-type="bibr">13</xref>]. Mammalian cells are known to express three types of NCX isoforms [<xref rid="ref14" ref-type="bibr">14</xref>,<xref rid="ref15" ref-type="bibr">15</xref>]. NCX1 is broadly expressed in various cells. It is particularly abundant in the heart, brain, and kidney. However, NCX2 is locally expressed in the brain and NCX3 is limitedly expressed in the brain and skeletal muscles. The direction of Ca<sup>2+</sup> movement depends on electrical and chemical gradients across the membrane. The forward mode of NCX generates an inward Na<sup>+</sup> current and an outward Ca<sup>2+</sup> current while the reverse-mode NCX promotes Na<sup>+</sup> efflux and Ca<sup>2+</sup> influx in plasma membrane. It is usually accepted that the forward NCX is favored at resting membrane potential and that reverse NCX (rNCX) may operate when the cell is physiologically depolarized [<xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr"/><xref rid="ref15" ref-type="bibr"/>-<xref rid="ref16" ref-type="bibr">16</xref>]. Na<sup>+</sup> dependency of GLP-1 secretion has been suggested because glucose-induced GLP-1 secretion can be blocked by replacing extracellular Na<sup>+</sup> with <italic>N</italic>-methyl-<sub>d</sub>-glucamine (NMG<sup>+</sup>) in GLUTag and intestinal L-cells [<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref17" ref-type="bibr">17</xref>]. Since the secretion of GLP-1 in response to nutrient or neural stimulation can be triggered by elevation of cytosolic Ca<sup>2+</sup>, extracellular Na<sup>+</sup> may be involved in the stimulus-secretion pathway of NCI-H716 cells. Therefore, the purpose of this study was to investigate the existence and the role of reverse Na<sup>+</sup>/Ca<sup>2+</sup> exchanger on Ca<sup>2+</sup> mobilization under cholinergic stimulation in NCI-H716 cells. Here we report that NCX1 is present on the plasma membrane and that rNCX contributes to calcium entry for calcium oscillation under cholinergic stimulation in NCI-H716, an enteroendocrine GLP-1 secreting cell line.</p>
</sec>
<sec sec-type="methods">
<title>METHODS</title>
<sec>
<title>Culture of NCI-H716 cells</title>
<p>Human enteroendocrine NCI-H716 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were maintained as a suspension culture in RPMI 1640 at 37&#176;C in a humidified atmosphere containing 5% CO<sub>2</sub> as described previously [<xref rid="ref18" ref-type="bibr">18</xref>]. Two days before experiments, endocrine differentiation and cell adhesion cells were initiated by seeding cells onto cover glass in 6-well culture plates coated with Matrigel (Becton Dickinson Co., Bedford, MA, USA) in high-glucose DMEM. On the day of experiments, to stabilize cultured cells and measure cytosolic Ca<sup>2+</sup>, cells were resuspended with HEPES-buffered physiological saline containing 137 mM NaCl, 4.7 mM KCl, 0.56 mM MgCl<sub>2</sub>, 1 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.28 mM CaCl<sub>2</sub>, 10 mM HEPES, and 5.5 mM glucose (pH 7.4).</p>
</sec><sec>
<title>Intracellular Ca<sup>2+</sup> measurements</title>
<p>Cultured cells were loaded with 5 &#956;M Fura-2/AM, a low affinity Ca<sup>2+</sup> sensitive dye, for 30 min at room temperature to measure intracellular Ca<sup>2+</sup>. Fura-2/AM loaded cells were continuously perfused with HEPES-buffered physiological saline. The perfusion rate was consistently controlled to be 1 ml/min using an electronically controlled perfusion system (Warner Instrument, Hamden, CT, USA). Intracellular Ca<sup>2+</sup> levels were monitored using a TILL Photonics imaging system (Till photonics, Pleasanton, CA, USA). Fura-2/AM loaded cells were excited alternately with light at 340 nm and 380 nm using a Polychrome V monochrometer (TILL Photonics). Fluorescence images emitted at 510 nm through 40&#215; fluorescence objective lens were captured using a Cool-SNAP HQ<sub>2</sub> camera (Photometrics, Tuscon, AZ, USA) attached to an Olympus IX71 inverted microscope (Olympus, Tokyo, Japan) [<xref rid="ref19" ref-type="bibr">19</xref>].</p>
</sec><sec>
<title>Western blots and immunocytochemistry</title>
<p>Protein samples were prepared from cultured NCI-H716 cells. Briefly, cells were pelleted and homogenized in an ice-cold lysis buffer containing 50 mM Tris/HCl, 2 mM EDTA, 10 mM EGTA, 5 mM DTT, 250 mM sucrose, 1% Triton X&#8211;100, and protease inhibitors (pH 7.5). Protein concentrations were measured using Bradford&#8217;s protein assay reagents (Bio-Rad Laboratories, Hercules, CA, USA). Samples were separated by 10% SDS-PAGE and transferred to nitrocellulose membrane at room temperature. After overnight incubation with polyclonal NCX1 primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 4&#176;C, membranes were then incubated with goat anti-rabbit IgG horseradish peroxidase secondary antibodies for 1 h at 37&#176;C. Bands were visualized using enhanced chemiluminescence. To determine distributions of NCX1, prepared NCI-H716 cells were placed on a poly-L-lysine coated glass coverslip for 10 min at room temperature prior to fixation with 2% formaldehyde in PBS solution. After fixation, nonspecific bindings were blocked by 1 h incubation in 3% BSA medium. The immunocytochemistry was performed using a primary NCX1 antibody and Cy-2 goat anti-rabbit secondary antibody. Immunofluorescence images for NCX1 were collected with an Olympus IX71 inverted microscope.</p>
</sec><sec>
<title>Data analysis</title>
<p>Change of cytosolic Ca<sup>2+</sup> was expressed as a representative trace in individual cells. Summated results were presented as mean &#177; SE. Differences were considered significant when the p-value was less than 0.05 using Student&#8217;s <italic>t</italic>-test.</p>
</sec></sec>
<sec sec-type="results">
<title>RESULTS</title>
<sec>
<title>Cholinergic stimulation induced cytosolic Ca<sup>2+</sup> oscillation</title>
<p>Initial experiments were performed to investigate if cholinergic stimuli could generate oscillatory cytosolic Ca<sup>2+</sup> signals in NCI-H716 cells. Changes of intracellular Ca<sup>2+</sup> concentration were monitored using various concentrations of carbamylcholine (CCh, 0.3 &#956;M&#8211;1 mM), a long-acting acetylcholine analog in the presence of 1.28 mM extracellular Ca<sup>2+</sup>. As shown in <xref rid="F1" ref-type="fig">Fig. 1A</xref>, the perfusion above 1 &#956;M of CCh for 100 sec evoked an initial Ca<sup>2+</sup> peak. Oscillatory Ca<sup>2+</sup> signals then continued. The maximum effect of initial Ca<sup>2+</sup> peak was observed at 100 &#956;M of CCh. Half maximum dosage of initial Ca<sup>2+</sup> peak was 0.85 &#177; 0.09 &#956;M of CCh. The maximum frequency of Ca<sup>2+</sup> oscillation was 12.02 &#177; 0.89 peaks/min. Half maximum effect was observed at 2.98 &#177; 0.47 &#956;M of CCh (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). These results suggest that cholinergic stimulation could sufficiently generate oscillatory Ca<sup>2+</sup> signals in NCI-H716 cells. Therefore, we used CCh at a concentration of 10 &#956;M in the following experiments to generate repetitive Ca<sup>2+</sup> oscillation. The following experiment was performed to determine whether voltage-operated Ca<sup>2+</sup> channel (VOC) was involved in CCh-induced calcium oscillation in NCI-H716 cells. As shown in <xref rid="F2" ref-type="fig">Fig. 2A</xref> and <xref rid="F2" ref-type="fig">2B</xref>, Ca<sup>2+</sup> oscillation signal induced by CCh was not suppressed by nifedipine, a VOC blocker. These results indicate that VOC does not participate in CCh-stimulated calcium influx in NCI-H716 cells.</p>
</sec><sec>
<title>Elimination of extracellular Na<sup>+</sup> terminates CCh-induced Ca<sup>2+</sup> oscillation</title>
<p>Next, we determined whether Na<sup>+</sup>/Ca<sup>2+</sup> exchanger could contribute to CCh-induced oscillatory Ca<sup>2+</sup> signals in NCI-H716 cells. Preferentially, we eliminated extracellular Na<sup>+</sup> by replacing Na<sup>+</sup> with NMG<sup>+</sup> or Li<sup>+</sup>. As shown in <xref rid="F3" ref-type="fig">Fig. 3A</xref>, the replacement of Na<sup>+</sup> with NMG<sup>+</sup> resulted in a slight enhancement of Ca<sup>2+</sup> oscillation pattern in the initial state, followed continuous decreases. Cytosolic Ca<sup>2+</sup> oscillation was complete terminated at about 120 sec after Na<sup>+</sup> elimination. Reintroduction of extracellular Na<sup>+</sup> resulted in a slow restoration of oscillatory Ca<sup>2+</sup> signals. When Na<sup>+</sup> was replaced with Li<sup>+</sup>, cytosolic Ca<sup>2+</sup> oscillation was slowly terminated similar to the replacement of Na<sup>+</sup> with NMG<sup>+</sup>. Such termination was then also partially recovered by Na<sup>+</sup> reperfusion (<xref rid="F3" ref-type="fig">Fig. 3B</xref>). these data indicate that extracellular Na<sup>+</sup> may be essential to Ca<sup>2+</sup> influx for the generation of oscillatory Ca<sup>2+</sup> signaling induced by muscarinic stimulation in the stimulus-secretion mechanism of NCI-H716 cells. Thus, the following experiment was planned to evaluate whether KB-R7943, a specific reverse-mode NCX blocker, could affect CCh-induced oscillatory Ca<sup>2+</sup> signaling in NCI-H716 cells.</p>
</sec><sec>
<title>Effects of KB-R7943 on CCh-induced Ca<sup>2+</sup> oscillation</title>
<p>Addition of KB-R7943 remarkably abolished 10 &#956;M CCh-induced Ca<sup>2+</sup> oscillation. Such abolishment was recovered by withdrawing KB-R7943 (<xref rid="F4" ref-type="fig">Fig. 4A</xref>). Similar results were observed when extracellular medium was changed to free Ca<sup>2+</sup> buffer (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). In contrast, pretreatment of KB-R7943 had no obvious effect on the initial Ca<sup>2+</sup> peak (<xref rid="F4" ref-type="fig">Fig. 4C, D</xref>). Indeed, cholinergic stimuli known to generate initial cytosolic Ca<sup>2+</sup> peaks with sustained oscillatory Ca<sup>2+</sup> signals. Initial Ca<sup>2+</sup> peaks are originated by inositol 1,4,5trisphospate-dependent calcium release from intracellular calcium stores and sustained Ca<sup>2+</sup> oscillation in need of calcium influx from extracellular medium in secretory cells [<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref21" ref-type="bibr">21</xref>]. In the present study, KB-R7943 reduced only maintenance of oscillatory Ca<sup>2+</sup> signaling without affecting initial Ca<sup>2+</sup> transients. These results lead us to conclude that rNCX might contribute to the generation of CCh-induced cytosolic Ca<sup>2+</sup> oscillation by modulating Ca<sup>2+</sup> influx pathways from extracellular fluid in NCI-H716 cells.</p>
</sec><sec>
<title>Expression of NCX1 proteins in NCI-H716 cells</title>
<p>In order to determine whether NCI-H716 cells could express NCX1 at the protein level, we performed Western blot analysis from prepared cell lysates using commercial primary antibodies to NCX1. NCX1 protein was detected in NCI-H716 cells at a band of about 120 kDa (<xref rid="F5" ref-type="fig">Fig. 5A</xref>). Additional band of a smaller size at 67 kDa probably represent proteolytic product of NCX protein. Such degradation product of NCX has well described in other tissues [<xref rid="ref22" ref-type="bibr">22</xref>]. In the immunocytochemical experiment on NCX1 protein localization, as shown in <xref rid="F5" ref-type="fig">Fig. 5B</xref>, NCX1 protein was expressed on NCI-H716 cells. There was no non-specific background staining in the negative experiment without primary antibody.</p>
</sec></sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>The present study provides evidence that reverse-mode NCX might significantly contribute to acetylcholine-induced Ca<sup>2+</sup> entry pathway of NCI-H716, a GLP-1 secreting cell line. Since GLP-1 is a well-known incretin hormone, many studies have been focused on stimulus-secretion mechanism of GLP-1 secreting cells to develop therapeutics for diabetes mellitus. In general, muscarinic receptors are closely linked to G-protein coupled receptor activation [<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr"/>-<xref rid="ref12" ref-type="bibr">12</xref>]. It is already known that muscarinic activation can enhance the secretion of GLP-1 in NCI-H716 cells [<xref rid="ref23" ref-type="bibr">23</xref>]. Thus, muscarinic agonists can mobilize Ca<sup>2+</sup> from internal stores through activation of InsP<sub>3</sub> receptors, which subsequently activates store-operated Ca<sup>2+</sup> entry from the external medium to refill depleted stores in NCI-H716 cells, similarly to other non-excitable epithelial cells [<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref21" ref-type="bibr">21</xref>]. However, these issues have not yet been addressed in detail. In this study, we confirmed that CCh could effectively generate oscillatory Ca<sup>2+</sup> signals in NCI-H716 cells. The initial Ca<sup>2+</sup> peak and the rhythmic Ca<sup>2+</sup> frequency induced by CCh were also increased in a dose-dependent manner. These results support that muscarinic receptor-mediated Ca<sup>2+</sup> signaling pathways which may act as a critical mechanism for regulating GLP-1 secretion are well operated in NCI-H716 cells.</p>
<p>In this study, for the first time, rhythmic calcium oscillation was observed in NCI-H716 cells by cholinergic stimulation. In general, repetitive and regular calcium oscillation can help intermittent message to include various information as the frequency, amplitude, and spatiotemporal characteristics of signals are different [<xref rid="ref24" ref-type="bibr">24</xref>,<xref rid="ref25" ref-type="bibr">25</xref>]. In part, calcium oscillation signals are known to be involved in various intracellular signaling processes including gene expression, exocytosis, and excitation-contraction coupling [<xref rid="ref25" ref-type="bibr">25</xref>]. Intracellular Ca<sup>2+</sup> oscillation signal is generated by a precise harmony between the mechanism of calcium mobilization and the mechanism of calcium extrusion [<xref rid="ref21" ref-type="bibr">21</xref>]. Calcium mobilization can be achieved by the secretion of calcium from the intracellular calcium reservoir and the influx of calcium from the extracellular fluid. Calcium extrusion is achieved by refilling of calcium into the cell reservoir and excretion of calcium to the extracellular space. The calcium signal is precisely controlled by the balance of the outflow process. Therefore, calcium oscillation signal, which is well observed in NCI-H716 cells after cholinergic stimulation, is highly likely to act as an important regulator in the secretion of GLP-1. It is not yet clear which types of calcium channels are involved in changes in intracellular calcium concentration in NCI-H716 cells. Some studies have reported that depolarization of cell membrane in GLP-1 secreting cells, such as GLUTag cells or primary intestinal cells, can promote the secretion of GLP-1 [<xref rid="ref26" ref-type="bibr">26</xref>,<xref rid="ref27" ref-type="bibr">27</xref>]. However, the oscillatory calcium signal induced by CCh was unaffected by voltage-operated Ca<sup>2+</sup> channel blocker nifedipine in this study. These results suggest that voltage-operated Ca<sup>2+</sup> channels do not participate in CCh-induced oscillatory calcium signals in NCI-H716 cells. Recently, sodium dependency on GLP-1 secretion in intestinal L-cells has been suggested because glucose-induced GLP-1 secretion can be blocked by replacement of extracellular Na<sup>+</sup> with NMG<sup>+</sup> [<xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref17" ref-type="bibr">17</xref>]. The present study also confirmed that when Na<sup>+</sup> in the extracellular fluid was removed by substituting NMG<sup>+</sup> or Li<sup>+</sup>, CCh-induced calcium oscillation disappeared. These results suggest that the calcium oscillation signal generated in NCI-H716 cells has a sodium dependence.</p>
<p>Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX), a bi-directional Ca<sup>2+</sup> transporter, is known to contribute to Ca<sup>2+</sup> homeostasis of multiple tissues [<xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr"/><xref rid="ref15" ref-type="bibr"/>-<xref rid="ref16" ref-type="bibr">16</xref>]. When cells are in an electrically or chemically activated state, reverse-mode NCX is known to promote Na<sup>+</sup> efflux and Ca<sup>2+</sup> influx through the plasma membrane. Muscarinic agonists not only can stimulate InsP<sub>3</sub> production, but also can promote the opening of non-selective cation channels followed by elevation of membrane potentials in various cell types [<xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr"/>-<xref rid="ref30" ref-type="bibr">30</xref>]. Thus, Na<sup>+</sup> introduced through non-selective cation channels might play an important role in Ca<sup>2+</sup> influx through rNCX under muscarinic stimulation in NCI-H716 cells. In this study, KB-R7943, a rNCX blocker, effectively attenuated CCh-induced cytosolic Ca<sup>2+</sup> oscillation. Furthermore, depletion of cytosolic Na<sup>+</sup> by replacement of Na<sup>+</sup> with NMG<sup>+</sup> or Li<sup>+</sup> also slowly reduced and terminated CCh-induced cytosolic Ca<sup>2+</sup> oscillation at about 120 sec after Na<sup>+</sup> elimination. These results indicate that muscarinic agonists can activate Na<sup>+</sup>-dependent Ca<sup>2+</sup> influx which might be closely linked to the generation of oscillatory Ca<sup>2+</sup> signals in NCI-H716 cells. In addition, as a result of the experiment using cell immunostaining method, it was confirmed that the receptor of NCX1 was present on NCI-H716 cells.</p>
<p>Based on data presented here, it can be concluded that rNCX is very closely involved in generation of oscillatory Ca<sup>2+</sup> signals promoted by CCh in NCI-H716 cells. Thus, rNCX might play a physiologically important role as a regulator of GLP-1 secretion in NCI-H716 cells.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>None.</p>
</ack>
<fn-group>
<fn fn-type="supported-by">
<p><bold>FUNDING</bold></p>
<p>This work was supported by the 2019 Konyang University Myunggok Research Fund.</p>
</fn>
<fn fn-type="conflict">
<p><bold>CONFLICTS OF INTEREST</bold></p>
<p>The authors declare no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kieffer</surname><given-names>TJ</given-names></name>
<name><surname>Habener</surname><given-names>JF</given-names></name>
</person-group>
<year>1999</year>
<article-title>The glucagon-like peptides</article-title>
<source>Endocr Rev</source>
<volume>20</volume>
<fpage>876</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="doi">10.1210/edrv.20.6.0385</pub-id>
<pub-id pub-id-type="pmid">10605628</pub-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fehmann</surname><given-names>HC</given-names></name>
<name><surname>G&#246;ke</surname><given-names>R</given-names></name>
<name><surname>G&#246;ke</surname><given-names>B</given-names></name>
</person-group>
<year>1992</year>
<article-title>Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin</article-title>
<source>Mol Cell Endocrinol</source>
<volume>85</volume>
<fpage>C39</fpage>
<lpage>C44</lpage>
<pub-id pub-id-type="doi">10.1016/0303-7207(92)90118-P</pub-id>
<pub-id pub-id-type="pmid">1382025</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname><given-names>X</given-names></name>
<name><surname>Guan</surname><given-names>Y</given-names></name>
<name><surname>Hua</surname><given-names>X</given-names></name>
</person-group>
<year>2014</year>
<article-title>Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic &#946;-cells</article-title>
<source>J Diabetes</source>
<volume>6</volume>
<fpage>394</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1111/1753-0407.12161</pub-id>
<pub-id pub-id-type="pmid">24725840</pub-id>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arulmozhi</surname><given-names>DK</given-names></name>
<name><surname>Portha</surname><given-names>B</given-names></name>
</person-group>
<year>2006</year>
<article-title>GLP-1 based therapy for type 2 diabetes</article-title>
<source>Eur J Pharm Sci</source>
<volume>28</volume>
<fpage>96</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejps.2006.01.003</pub-id>
<pub-id pub-id-type="pmid">16488579</pub-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Abbas</surname><given-names>G</given-names></name>
<name><surname>Haq</surname><given-names>QMI</given-names></name>
<name><surname>Hamaed</surname><given-names>A</given-names></name>
<name><surname>Al-Sibani</surname><given-names>M</given-names></name>
<name><surname>Hussain</surname><given-names>H</given-names></name>
</person-group>
<year>2020</year>
<article-title>Glucagon and glucagon-like peptide-1 receptors: promising therapeutic targets for an effective management of diabetes mellitus</article-title>
<source>Curr Pharm Des</source>
<volume>26</volume>
<fpage>501</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="doi">10.2174/1381612826666200131143231</pub-id>
<pub-id pub-id-type="pmid">32003684</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kuhre</surname><given-names>RE</given-names></name>
<name><surname>Wewer Albrechtsen</surname><given-names>NJ</given-names></name>
<name><surname>Deacon</surname><given-names>CF</given-names></name>
<name><surname>Balk-M&#248;ller</surname><given-names>E</given-names></name>
<name><surname>Rehfeld</surname><given-names>JF</given-names></name>
<name><surname>Reimann</surname><given-names>F</given-names></name>
<name><surname>Gribble</surname><given-names>FM</given-names></name>
<name><surname>Holst</surname><given-names>JJ</given-names></name>
</person-group>
<year>2016</year>
<article-title>Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells</article-title>
<source>J Mol Endocrinol</source>
<volume>56</volume>
<fpage>201</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1530/JME-15-0293</pub-id>
<pub-id pub-id-type="pmid">26819328</pub-id>
<pub-id pub-id-type="pmcid">PMC7212058</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sun</surname><given-names>EW</given-names></name>
<name><surname>de Fontgalland</surname><given-names>D</given-names></name>
<name><surname>Rabbitt</surname><given-names>P</given-names></name>
<name><surname>Hollington</surname><given-names>P</given-names></name>
<name><surname>Sposato</surname><given-names>L</given-names></name>
<name><surname>Due</surname><given-names>SL</given-names></name>
<name><surname>Wattchow</surname><given-names>DA</given-names></name>
<name><surname>Rayner</surname><given-names>CK</given-names></name>
<name><surname>Deane</surname><given-names>AM</given-names></name>
<name><surname>Young</surname><given-names>RL</given-names></name>
<name><surname>Keating</surname><given-names>DJ</given-names></name>
</person-group>
<year>2017</year>
<article-title>Mechanisms controlling glucose-induced GLP-1 secretion in human small intestine</article-title>
<source>Diabetes</source>
<volume>66</volume>
<fpage>2144</fpage>
<lpage>2149</lpage>
<pub-id pub-id-type="doi">10.2337/db17-0058</pub-id>
<pub-id pub-id-type="pmid">28385801</pub-id>
<pub-id pub-id-type="pmcid">PMC5860185</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Holst</surname><given-names>JJ</given-names></name>
</person-group>
<year>2007</year>
<article-title>The physiology of glucagon-like peptide 1</article-title>
<source>Physiol Rev</source>
<volume>87</volume>
<fpage>1409</fpage>
<lpage>1439</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00034.2006</pub-id>
<pub-id pub-id-type="pmid">17928588</pub-id>
</element-citation>
</ref>
<ref id="ref9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Goldspink</surname><given-names>DA</given-names></name>
<name><surname>Lu</surname><given-names>VB</given-names></name>
<name><surname>Miedzybrodzka</surname><given-names>EL</given-names></name>
<name><surname>Smith</surname><given-names>CA</given-names></name>
<name><surname>Foreman</surname><given-names>RE</given-names></name>
<name><surname>Billing</surname><given-names>LJ</given-names></name>
<name><surname>Kay</surname><given-names>RG</given-names></name>
<name><surname>Reimann</surname><given-names>F</given-names></name>
<name><surname>Gribble</surname><given-names>FM</given-names></name>
</person-group>
<year>2020</year>
<article-title>Labeling and characterization of human GLP-1-secreting L-cells in primary ileal organoid culture</article-title>
<source>Cell Rep</source>
<volume>31</volume>
<elocation-id>107833</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.celrep.2020.107833</pub-id>
<pub-id pub-id-type="pmid">32610134</pub-id>
<pub-id pub-id-type="pmcid">PMC7342002</pub-id>
</element-citation>
</ref>
<ref id="ref10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Reimer</surname><given-names>RA</given-names></name>
<name><surname>Darimont</surname><given-names>C</given-names></name>
<name><surname>Gremlich</surname><given-names>S</given-names></name>
<name><surname>Nicolas-M&#233;tral</surname><given-names>V</given-names></name>
<name><surname>R&#252;egg</surname><given-names>UT</given-names></name>
<name><surname>Mac&#233;</surname><given-names>K</given-names></name>
</person-group>
<year>2001</year>
<article-title>A human cellular model for studying the regulation of glucagon-like peptide-1 secretion</article-title>
<source>Endocrinology</source>
<volume>142</volume>
<fpage>4522</fpage>
<lpage>4528</lpage>
<pub-id pub-id-type="doi">10.1210/endo.142.10.8415</pub-id>
<pub-id pub-id-type="pmid">11564718</pub-id>
</element-citation>
</ref>
<ref id="ref11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Le Nev&#233;</surname><given-names>B</given-names></name>
<name><surname>Daniel</surname><given-names>H</given-names></name>
</person-group>
<year>2011</year>
<article-title>Selected tetrapeptides lead to a GLP-1 release from the human enteroendocrine cell line NCI-H716</article-title>
<source>Regul Pept</source>
<volume>167</volume>
<fpage>14</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.regpep.2010.10.010</pub-id>
<pub-id pub-id-type="pmid">21070823</pub-id>
</element-citation>
</ref>
<ref id="ref12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Suh</surname><given-names>HW</given-names></name>
<name><surname>Lee</surname><given-names>KB</given-names></name>
<name><surname>Kim</surname><given-names>KS</given-names></name>
<name><surname>Yang</surname><given-names>HJ</given-names></name>
<name><surname>Choi</surname><given-names>EK</given-names></name>
<name><surname>Shin</surname><given-names>MH</given-names></name>
<name><surname>Park</surname><given-names>YS</given-names></name>
<name><surname>Na</surname><given-names>YC</given-names></name>
<name><surname>Ahn</surname><given-names>KS</given-names></name>
<name><surname>Jang</surname><given-names>YP</given-names></name>
<name><surname>Um</surname><given-names>JY</given-names></name>
<name><surname>Jang</surname><given-names>HJ</given-names></name>
</person-group>
<year>2015</year>
<article-title>A bitter herbal medicine Gentiana scabra root extract stimulates glucagon-like peptide-1 secretion and regulates blood glucose in db/db mouse</article-title>
<source>J Ethnopharmacol</source>
<volume>172</volume>
<fpage>219</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2015.06.042</pub-id>
<pub-id pub-id-type="pmid">26129938</pub-id>
</element-citation>
</ref>
<ref id="ref13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Annunziato</surname><given-names>L</given-names></name>
<name><surname>Pignataro</surname><given-names>G</given-names></name>
<name><surname>Di Renzo</surname><given-names>GF</given-names></name>
</person-group>
<year>2004</year>
<article-title>Pharmacology of brain Na<sup>+</sup>/Ca<sup>2+</sup> exchanger: from molecular biology to therapeutic perspectives</article-title>
<source>Pharmacol Rev</source>
<volume>56</volume>
<fpage>633</fpage>
<lpage>654</lpage>
<pub-id pub-id-type="doi">10.1124/pr.56.4.5</pub-id>
<pub-id pub-id-type="pmid">15602012</pub-id>
</element-citation>
</ref>
<ref id="ref14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lytton</surname><given-names>J</given-names></name>
</person-group>
<year>2007</year>
<article-title>Na<sup>+</sup>/Ca<sup>2+</sup> exchangers: three mammalian gene families control Ca<sup>2+</sup> transport</article-title>
<source>Biochem J</source>
<volume>406</volume>
<fpage>365</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20070619</pub-id>
<pub-id pub-id-type="pmid">17716241</pub-id>
</element-citation>
</ref>
<ref id="ref15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Philipson</surname><given-names>KD</given-names></name>
<name><surname>Nicoll</surname><given-names>DA</given-names></name>
</person-group>
<year>2000</year>
<article-title>Sodium-calcium exchange: a molecular perspective</article-title>
<source>Annu Rev Physiol</source>
<volume>62</volume>
<fpage>111</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.physiol.62.1.111</pub-id>
<pub-id pub-id-type="pmid">10845086</pub-id>
</element-citation>
</ref>
<ref id="ref16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hirota</surname><given-names>S</given-names></name>
<name><surname>Pertens</surname><given-names>E</given-names></name>
<name><surname>Janssen</surname><given-names>LJ</given-names></name>
</person-group>
<year>2007</year>
<article-title>The reverse mode of the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger provides a source of Ca<sup>2+</sup> for store refilling following agonist-induced Ca<sup>2+</sup> mobilization</article-title>
<source>Am J Physiol Lung Cell Mol Physiol</source>
<volume>292</volume>
<fpage>L438</fpage>
<lpage>L447</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00222.2006</pub-id>
<pub-id pub-id-type="pmid">17041014</pub-id>
</element-citation>
</ref>
<ref id="ref17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tolhurst</surname><given-names>G</given-names></name>
<name><surname>Zheng</surname><given-names>Y</given-names></name>
<name><surname>Parker</surname><given-names>HE</given-names></name>
<name><surname>Habib</surname><given-names>AM</given-names></name>
<name><surname>Reimann</surname><given-names>F</given-names></name>
<name><surname>Gribble</surname><given-names>FM</given-names></name>
</person-group>
<year>2011</year>
<article-title>Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca<sup>2+</sup> and cAMP</article-title>
<source>Endocrinology</source>
<volume>152</volume>
<fpage>405</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1210/en.2010-0956</pub-id>
<pub-id pub-id-type="pmid">21209017</pub-id>
<pub-id pub-id-type="pmcid">PMC3140224</pub-id>
</element-citation>
</ref>
<ref id="ref18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jang</surname><given-names>HJ</given-names></name>
<name><surname>Kokrashvili</surname><given-names>Z</given-names></name>
<name><surname>Theodorakis</surname><given-names>MJ</given-names></name>
<name><surname>Carlson</surname><given-names>OD</given-names></name>
<name><surname>Kim</surname><given-names>BJ</given-names></name>
<name><surname>Zhou</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>HH</given-names></name>
<name><surname>Xu</surname><given-names>X</given-names></name>
<name><surname>Chan</surname><given-names>SL</given-names></name>
<name><surname>Juhaszova</surname><given-names>M</given-names></name>
<name><surname>Bernier</surname><given-names>M</given-names></name>
<name><surname>Mosinger</surname><given-names>B</given-names></name>
<name><surname>Margolskee</surname><given-names>RF</given-names></name>
<name><surname>Egan</surname><given-names>JM</given-names></name>
</person-group>
<year>2007</year>
<article-title>Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>
<fpage>15069</fpage>
<lpage>15074</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0706890104</pub-id>
<pub-id pub-id-type="pmid">17724330</pub-id>
<pub-id pub-id-type="pmcid">PMC1986614</pub-id>
</element-citation>
</ref>
<ref id="ref19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>MJ</given-names></name>
<name><surname>Choi</surname><given-names>KJ</given-names></name>
<name><surname>Yoon</surname><given-names>MN</given-names></name>
<name><surname>Oh</surname><given-names>SH</given-names></name>
<name><surname>Kim</surname><given-names>DK</given-names></name>
<name><surname>Kim</surname><given-names>SH</given-names></name>
<name><surname>Park</surname><given-names>HS</given-names></name>
</person-group>
<year>2018</year>
<article-title>Hydrogen peroxide inhibits Ca<sup>2+</sup> efflux through plasma membrane Ca<sup>2+</sup>-ATPase in mouse parotid acinar cells</article-title>
<source>Korean J Physiol Pharmacol</source>
<volume>22</volume>
<fpage>215</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.4196/kjpp.2018.22.2.215</pub-id>
<pub-id pub-id-type="pmid">29520174</pub-id>
<pub-id pub-id-type="pmcid">PMC5840080</pub-id>
</element-citation>
</ref>
<ref id="ref20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Park</surname><given-names>HS</given-names></name>
<name><surname>Betzenhauser</surname><given-names>MJ</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Yule</surname><given-names>DI</given-names></name>
</person-group>
<year>2012</year>
<article-title>Regulation of Ca&#178;<sup>+</sup> release through inositol 1,4,5-trisphosphate receptors by adenine nucleotides in parotid acinar cells</article-title>
<source>Am J Physiol Gastrointest Liver Physiol</source>
<volume>302</volume>
<fpage>G97</fpage>
<lpage>G104</lpage>
<pub-id pub-id-type="doi">10.1152/ajpgi.00328.2011</pub-id>
<pub-id pub-id-type="pmid">21960523</pub-id>
<pub-id pub-id-type="pmcid">PMC3345966</pub-id>
</element-citation>
</ref>
<ref id="ref21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Petersen</surname><given-names>OH</given-names></name>
</person-group>
<year>2017</year>
<article-title>The effects of Ca<sup>2+</sup> buffers on cytosolic Ca<sup>2+</sup> signalling</article-title>
<source>J Physiol</source>
<volume>595</volume>
<fpage>3107</fpage>
<lpage>3108</lpage>
<pub-id pub-id-type="doi">10.1113/JP273852</pub-id>
<pub-id pub-id-type="pmid">28058721</pub-id>
<pub-id pub-id-type="pmcid">PMC5430207</pub-id>
</element-citation>
</ref>
<ref id="ref22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Philipson</surname><given-names>KD</given-names></name>
<name><surname>Longoni</surname><given-names>S</given-names></name>
<name><surname>Ward</surname><given-names>R</given-names></name>
</person-group>
<year>1988</year>
<article-title>Purification of the cardiac Na<sup>+</sup>-Ca<sup>2+</sup> exchange protein</article-title>
<source>Biochim Biophys Acta</source>
<volume>945</volume>
<fpage>298</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1016/0005-2736(88)90492-0</pub-id>
<pub-id pub-id-type="pmid">3191125</pub-id>
</element-citation>
</ref>
<ref id="ref23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Anini</surname><given-names>Y</given-names></name>
<name><surname>Brubaker</surname><given-names>PL</given-names></name>
</person-group>
<year>2003</year>
<article-title>Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells</article-title>
<source>Endocrinology</source>
<volume>144</volume>
<fpage>3244</fpage>
<lpage>3250</lpage>
<pub-id pub-id-type="doi">10.1210/en.2003-0143</pub-id>
<pub-id pub-id-type="pmid">12810581</pub-id>
</element-citation>
</ref>
<ref id="ref24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Parekh</surname><given-names>AB</given-names></name>
</person-group>
<year>2011</year>
<article-title>Decoding cytosolic Ca<sup>2+</sup> oscillations</article-title>
<source>Trends Biochem Sci</source>
<volume>36</volume>
<fpage>78</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1016/j.tibs.2010.07.013</pub-id>
<pub-id pub-id-type="pmid">20810284</pub-id>
</element-citation>
</ref>
<ref id="ref25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Smedler</surname><given-names>E</given-names></name>
<name><surname>Uhl&#233;n</surname><given-names>P</given-names></name>
</person-group>
<year>2014</year>
<article-title>Frequency decoding of calcium oscillations</article-title>
<source>Biochim Biophys Acta</source>
<volume>1840</volume>
<fpage>964</fpage>
<lpage>969</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2013.11.015</pub-id>
<pub-id pub-id-type="pmid">24269537</pub-id>
</element-citation>
</ref>
<ref id="ref26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Reimann</surname><given-names>F</given-names></name>
<name><surname>Maziarz</surname><given-names>M</given-names></name>
<name><surname>Flock</surname><given-names>G</given-names></name>
<name><surname>Habib</surname><given-names>AM</given-names></name>
<name><surname>Drucker</surname><given-names>DJ</given-names></name>
<name><surname>Gribble</surname><given-names>FM</given-names></name>
</person-group>
<year>2005</year>
<article-title>Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line</article-title>
<source>J Physiol</source>
<volume>563</volume>
<issue>Pt 1</issue>
<fpage>161</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.076414</pub-id>
<pub-id pub-id-type="pmid">15611035</pub-id>
<pub-id pub-id-type="pmcid">PMC1665554</pub-id>
</element-citation>
</ref>
<ref id="ref27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Goldspink</surname><given-names>DA</given-names></name>
<name><surname>Lu</surname><given-names>VB</given-names></name>
<name><surname>Billing</surname><given-names>LJ</given-names></name>
<name><surname>Larraufie</surname><given-names>P</given-names></name>
<name><surname>Tolhurst</surname><given-names>G</given-names></name>
<name><surname>Gribble</surname><given-names>FM</given-names></name>
<name><surname>Reimann</surname><given-names>F</given-names></name>
</person-group>
<year>2018</year>
<article-title>Mechanistic insights into the detection of free fatty and bile acids by ileal glucagon-like peptide-1 secreting cells</article-title>
<source>Mol Metab</source>
<volume>7</volume>
<fpage>90</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmet.2017.11.005</pub-id>
<pub-id pub-id-type="pmid">29167062</pub-id>
<pub-id pub-id-type="pmcid">PMC5784317</pub-id>
</element-citation>
</ref>
<ref id="ref28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McCandless</surname><given-names>M</given-names></name>
<name><surname>Nishiyama</surname><given-names>A</given-names></name>
<name><surname>Petersen</surname><given-names>OH</given-names></name>
<name><surname>Philpott</surname><given-names>HG</given-names></name>
</person-group>
<year>1981</year>
<article-title>Mouse pancreatic acinar cells: voltage-clamp study of acetylcholine-evoked membrane current</article-title>
<source>J Physiol</source>
<volume>318</volume>
<fpage>57</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.1981.sp013850</pub-id>
<pub-id pub-id-type="pmid">7320904</pub-id>
<pub-id pub-id-type="pmcid">PMC1245477</pub-id>
</element-citation>
</ref>
<ref id="ref29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Morris</surname><given-names>AP</given-names></name>
<name><surname>Fuller</surname><given-names>CM</given-names></name>
<name><surname>Gallacher</surname><given-names>DV</given-names></name>
</person-group>
<year>1987</year>
<article-title>Cholinergic receptors regulate a voltage-insensitive but Na<sup>+</sup>-dependent calcium influx pathway in salivary acinar cells</article-title>
<source>FEBS Lett</source>
<volume>211</volume>
<fpage>195</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1016/0014-5793(87)81435-7</pub-id>
<pub-id pub-id-type="pmid">3803598</pub-id>
</element-citation>
</ref>
<ref id="ref30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>So</surname><given-names>I</given-names></name>
<name><surname>Kim</surname><given-names>KW</given-names></name>
</person-group>
<year>2003</year>
<article-title>Nonselective cation channels activated by the stimulation of muscarinic receptors in mammalian gastric smooth muscle</article-title>
<source>J Smooth Muscle Res</source>
<volume>39</volume>
<fpage>231</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1540/jsmr.39.231</pub-id>
<pub-id pub-id-type="pmid">15048016</pub-id>
</element-citation>
</ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="F1" position="float">
<label>Fig. 1</label>
<caption>
<title>Dose-dependent Ca<sup>2+</sup> oscillation induced by carbamylcholine (CCh) in NCI-H716 cells.</title>
<p>(A) Representative cytosolic Ca<sup>2+</sup> oscillation obtained from stepwise increase of various concentration of CCh (0.3 &#956;M&#8211;1 mM) every 100 sec. (B) CCh-induced initial Ca<sup>2+</sup> peak (% of maximum) and frequency of Ca<sup>2+</sup> oscillation (peaks/min). Cytosolic Ca<sup>2+</sup> measurement was obtained from seven separate experiments in fura-2 loaded NCI-H716 cells. CCh significantly stimulated initial Ca<sup>2+</sup> peak and frequency of Ca<sup>2+</sup> oscillation, dose-dependently.</p>
</caption>
<graphic xlink:href="kjpp-26-3-219-f1.tif"/>
</fig>
<fig id="F2" position="float">
<label>Fig. 2</label>
<caption>
<title>Voltage-operated Ca<sup>2+</sup> channel (VOC) does not contribute to carbamylcholine (CCh)-induced Ca<sup>2+</sup> entry process in NCI-H716 cells.</title>
<p>(A) Nifedipine, a VOC antagonist, failed to change CCh-induced Ca<sup>2+</sup> oscillation in NCI-H716 cells. (B) CCh-induced frequency of Ca<sup>2+</sup> oscillation was not changed by nifedipine treatment. Similar results were obtained from six separate experiments in NCI-H716 cells. VOC might not be involved in the calcium influx in CCh-stimulated NCI-H716 cells.</p>
</caption>
<graphic xlink:href="kjpp-26-3-219-f2.tif"/>
</fig>
<fig id="F3" position="float">
<label>Fig. 3</label>
<caption>
<title>Effects of extracellular free Na<sup>+</sup> on carbamylcholine (CCh)-induced Ca<sup>2+</sup> oscillation in NCI-H716 cells.</title>
<p>(A) Substitution of Na<sup>+</sup> with <italic>N</italic>-methyl-<sub>d</sub>-glucamine (NMG<sup>+</sup>) resulted in cessation of Ca<sup>2+</sup> oscillation, which was restored by Na<sup>+</sup> reperfusion. (B) Replacing Na<sup>+</sup> with Li<sup>+</sup> resulted in termination of cytosolic Ca<sup>2+</sup> oscillation and restoration of oscillatory Ca<sup>2+</sup> signals by Na<sup>+</sup> reperfusion. Na<sup>+</sup>-dependent Ca<sup>2+</sup> influx might be important for the generation of oscillatory Ca<sup>2+</sup> signaling induced by muscarinic stimulation in stimulus-secretion mechanism of NCI-H716 cells.</p>
</caption>
<graphic xlink:href="kjpp-26-3-219-f3.tif"/>
</fig>
<fig id="F4" position="float">
<label>Fig. 4</label>
<caption>
<title>Effects of KB-R7943 on carbamylcholine (CCh)-induced Ca<sup>2+</sup> oscillation in NCI-H716 cells.</title>
<p>(A) KB-R7943 significantly blocked CCh-induced Ca<sup>2+</sup> oscillation in NCI-H716 cells. Ca<sup>2+</sup> oscillation was restored after cessation of KB-R7943 perfusion. (B) Elimination of extracellular Ca<sup>2+</sup> resulted in complete inhibition of CCh-induced Ca<sup>2+</sup> oscillation. (C) Pretreatment of KB-R7943 failed to inhibit initial Ca<sup>2+</sup> peak induced by CCh. (D) Effect KB-R7943 on CCh-induced initial Ca<sup>2+</sup> peak obtained from seven separate experiments. rNCX might contribute to the generation of CCh-induced cytosolic Ca<sup>2+</sup> oscillation by modulating Ca<sup>2+</sup> influx pathway from extracellular fluid in NCI-H716 cells.</p>
</caption>
<graphic xlink:href="kjpp-26-3-219-f4.tif"/>
</fig>
<fig id="F5" position="float">
<label>Fig. 5</label>
<caption>
<title>Type 1 Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX1) protein expression and distribution in NCI-H716 cells.</title>
<p>(A) Western blot analysis of NCX1 expression. NCX1 protein was detected in NCI-H716 cells at band of about 120 kDa, and small sized proteolytic product band of 67 kDa was additionally detected. (B) Immunocytochemistry for NCX1 protein expression. Corresponding bright-field (top) and immunofluorescence (bottom) microscopy images showing the labelling of NCX1 protein. NCX1 protein was remarkably expressed on NCI-H716 cells, scale bars = 10 &#956;m.</p>
</caption>
<graphic xlink:href="kjpp-26-3-219-f5.tif"/>
</fig>
</sec>
</back>
</article>